Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 68-2022

To publish the April 26, 2022 letter of the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
68
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 68-2022 (issued May 12, 2022) publishes the April 26, 2022 letter of FDA OIC-Director General Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The updated list covers medicines prescribed for hypertension, diabetes, high cholesterol, kidney diseases, mental illnesses, tuberculosis, cancer, and COVID-19 treatment. The provided text does not include the actual itemized list.